Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02006719 · ClinicalTrials.gov registry record · Phase 2

Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder

A Phase 2 study of Frozen Shoulder and Adhesive Capsulitis, sponsored by Endo Pharmaceuticals.

Completed
Registry status
Phase 2
Development phase
322
Enrollment target
20
Study locations

NCT02006719 is a Phase 2 study of Frozen Shoulder and Adhesive Capsulitis that has completed, run by Endo Pharmaceuticals. The registered enrollment target is 322 participants, above the 109-participant average among 3 other Frozen Shoulder trials with a reported enrollment target (195% higher). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02006719, a Phase 2 study of Frozen Shoulder and Adhesive Capsulitis, has completed, sponsored by Endo Pharmaceuticals.

COMPLETED
Registry status
Phase 2
Development phase
322 participants
Enrollment target
20
Study locations

Study Summary

The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.

Conditions Studied

Frozen Shoulder Adhesive Capsulitis

Interventions

  • OTHER Placebo
  • BIOLOGICAL Collagenase Clostridium Histolyticum

Study Locations (20)

California

  • Advance Med Clinical Research - Carlsbad
  • Triwest Research Associates - El Cajon
  • Core Orthopedic Medical Center - Encinitas
  • Temecula Rheumatology & Internal Medicine - Murrieta
  • Clearview Medical Research - Santa Clarita

Florida

  • Florida Research Associates - DeLand
  • Shrock Orthopedic Research, LLC - Fort Lauderdale
  • Jewett Orthopedic Clinic - Orlando
  • Clinical Research of West Florida - Tampa

Alabama

  • Alabama Orthopaedic Center-Research - Birmingham
  • Coastal Clinical Research - Mobile

Illinois

  • Rockford Orthopedic Associates - Rockford
  • Rockford Orthopedics Associates - Rockford

Arizona

  • Arizona Research Center, Inc. - Phoenix

Colorado

  • Colorado Orthopedic Consultants, PC - Englewood

Georgia

  • Non-Surgical Orthopedics, P.C. / Georgia Institute for Clinical Research, LLC - Marietta

Idaho

  • Injury Care Medical Center - Boise

Trial Details

FieldValue
Enrollment Target 322 participants
Start Date 2013-11
Est. Completion 2014-12
Phase Phase 2

Sponsor

Endo Pharmaceuticals

23 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02006719

The ClinicalTrials.gov registry entry for NCT02006719 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 109-participant average among 3 other Frozen Shoulder trials with a reported enrollment target (195% higher). The listed sponsor is Endo Pharmaceuticals, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Frozen Shoulder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02006719 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Florida, Alabama.

Frequently Asked Questions

What is clinical trial NCT02006719 about?

NCT02006719 is a clinical study titled "Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder". The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.

What is the current status of trial NCT02006719?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 322 participants. The study started on 2013-11. Estimated completion is 2014-12.

What conditions does trial NCT02006719 study?

This clinical trial studies the following conditions: Frozen Shoulder, Adhesive Capsulitis.

What interventions are being tested in trial NCT02006719?

The interventions under investigation include: Placebo (OTHER), Collagenase Clostridium Histolyticum (BIOLOGICAL).

Who is sponsoring clinical trial NCT02006719?

This trial is sponsored by Endo Pharmaceuticals, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02006719 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Frozen Shoulder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Frozen Shoulder

All registered trials for this condition

Adhesive Capsulitis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.